KIIIB Recombinant Proteins 

KIIIB recombinant proteins are engineered versions of proteins derived from Protein Kinase IIIB (also referred to as Casein Kinase IIIB or related variants). These proteins are serine/threonine kinases involved in various cellular signaling pathways, including those regulating cell growth, differentiation, apoptosis, and stress responses. 

Content on KIIIB Recombinant Proteins
  • Structure and Function
    • KIIIB is a member of the protein kinase family, characterized by:
      • Catalytic Domain: Responsible for ATP binding and phosphorylation of substrates.
      • Regulatory Regions: Modulate activity through interactions with cofactors or post-translational modifications.
    • Plays roles in:
      • Phosphorylation of intracellular proteins, including transcription factors, metabolic enzymes, and cytoskeletal components.
      • Modulating signal transduction pathways linked to cellular stress and survival.
Applications of KIIIB Recombinant Proteins
  • Signal Transduction Research
    • Study the role of KIIIB in phosphorylation events that regulate cell signaling cascades.
    • Analyze its involvement in cross-talk between multiple pathways, including stress and survival signaling.
  • Cancer Research
    • Investigate dysregulated KIIIB activity in tumorigenesis and cancer progression.
    • Explore KIIIB as a therapeutic target for developing kinase inhibitors in oncology.
  • Neurobiology Studies
    • Study the role of KIIIB in neuronal signaling, synaptic plasticity, and neuroprotection.
    • Investigate its dysregulation in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
  • Drug Discovery and Screening
    • Screen small-molecule inhibitors or activators targeting KIIIB kinase activity.
    • Develop structure-based drugs by studying KIIIB-ligand interactions.

KIIIB recombinant proteins are essential tools for advancing research in kinase signaling, disease mechanisms, and drug development, providing valuable insights into cellular regulation and potential therapeutic targets.